Medical - Distribution
Compare Stocks
2 / 10Stock Comparison
OMI vs MMSI
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
OMI vs MMSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Distribution | Medical - Instruments & Supplies |
| Market Cap | $171M | $3.72B |
| Revenue (TTM) | $2.76B | $1.54B |
| Net Income (TTM) | $-1.10B | $139M |
| Gross Margin | — | 48.7% |
| Operating Margin | 1.0% | 12.2% |
| Forward P/E | 2.3x | 15.5x |
| Total Debt | $320M | $898M |
| Cash & Equiv. | $282M | $449M |
OMI vs MMSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Feb 26 | Return |
|---|---|---|---|
| Owens & Minor, Inc. (OMI) | 100 | 28.2 | -71.8% |
| Merit Medical Syste… (MMSI) | 100 | 180.2 | +80.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OMI vs MMSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OMI is the clearest fit if your priority is value.
- Lower P/E (2.3x vs 15.5x)
MMSI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.71
- Rev growth 11.7%, EPS growth 4.9%, 3Y rev CAGR 9.6%
- 214.6% 10Y total return vs OMI's -86.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.7% revenue growth vs OMI's -74.2% | |
| Value | Lower P/E (2.3x vs 15.5x) | |
| Quality / Margins | 9.0% margin vs OMI's -39.8% | |
| Stability / Safety | Beta 0.71 vs OMI's 1.44 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -33.8% vs OMI's -71.1% | |
| Efficiency (ROA) | 5.2% ROA vs OMI's -44.9%, ROIC 7.2% vs 1.8% |
OMI vs MMSI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OMI vs MMSI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MMSI leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
OMI is the larger business by revenue, generating $2.8B annually — 1.8x MMSI's $1.5B. MMSI is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to OMI's -39.8%. On growth, MMSI holds the edge at +7.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.8B | $1.5B |
| EBITDAEarnings before interest/tax | $277M | $290M |
| Net IncomeAfter-tax profit | -$1.1B | $139M |
| Free Cash FlowCash after capex | -$353M | $274M |
| Gross MarginGross profit ÷ Revenue | — | +48.7% |
| Operating MarginEBIT ÷ Revenue | +1.0% | +12.2% |
| Net MarginNet income ÷ Revenue | -39.8% | +9.0% |
| FCF MarginFCF ÷ Revenue | -12.8% | +17.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -146.3% | +7.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.5% | +38.8% |
Valuation Metrics
OMI leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than MMSI's 13.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $171M | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $209M | $4.2B |
| Trailing P/EPrice ÷ TTM EPS | -0.16x | 29.26x |
| Forward P/EPrice ÷ next-FY EPS est. | 2.31x | 15.46x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 1.70x | 13.06x |
| Price / SalesMarket cap ÷ Revenue | 0.06x | 2.45x |
| Price / BookPrice ÷ Book value/share | — | 2.38x |
| Price / FCFMarket cap ÷ FCF | — | 17.24x |
Profitability & Efficiency
MMSI leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
MMSI delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-21 for OMI. On the Piotroski fundamental quality scale (0–9), MMSI scores 6/9 vs OMI's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -21.1% | +8.9% |
| ROA (TTM)Return on assets | -44.9% | +5.2% |
| ROICReturn on invested capital | +1.8% | +7.2% |
| ROCEReturn on capital employed | +1.3% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 |
| Debt / EquityFinancial leverage | — | 0.57x |
| Net DebtTotal debt minus cash | $38M | $450M |
| Cash & Equiv.Liquid assets | $282M | $449M |
| Total DebtShort + long-term debt | $320M | $898M |
| Interest CoverageEBIT ÷ Interest expense | -0.12x | 10.74x |
Total Returns (Dividends Reinvested)
MMSI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MMSI five years ago would be worth $9,644 today (with dividends reinvested), compared to $655 for OMI. Over the past 12 months, MMSI leads with a -33.8% total return vs OMI's -71.1%. The 3-year compound annual growth rate (CAGR) favors MMSI at -9.8% vs OMI's -49.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -3.4% | -27.9% |
| 1-Year ReturnPast 12 months | -71.1% | -33.8% |
| 3-Year ReturnCumulative with dividends | -87.4% | -26.5% |
| 5-Year ReturnCumulative with dividends | -93.5% | -3.6% |
| 10-Year ReturnCumulative with dividends | -86.2% | +214.6% |
| CAGR (3Y)Annualised 3-year return | -49.9% | -9.8% |
Risk & Volatility
MMSI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MMSI is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MMSI currently trades 62.2% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 0.71x |
| 52-Week HighHighest price in past year | $9.55 | $100.19 |
| 52-Week LowLowest price in past year | $1.84 | $59.74 |
| % of 52W HighCurrent price vs 52-week peak | +23.5% | +62.2% |
| RSI (14)Momentum oscillator 0–100 | 46.5 | 34.9 |
| Avg Volume (50D)Average daily shares traded | 690K | 769K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates OMI as "Hold" and MMSI as "Buy". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 52.4% for MMSI (target: $95).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $4.00 | $95.00 |
| # AnalystsCovering analysts | 10 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
MMSI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OMI leads in 1 (Valuation Metrics).
OMI vs MMSI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is OMI or MMSI a better buy right now?
For growth investors, Merit Medical Systems, Inc.
(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Merit Medical Systems, Inc. (MMSI) offers the better valuation at 29. 3x trailing P/E (15. 5x forward), making it the more compelling value choice. Analysts rate Merit Medical Systems, Inc. (MMSI) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OMI or MMSI?
On forward P/E, Owens & Minor, Inc.
is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — OMI or MMSI?
Over the past 5 years, Merit Medical Systems, Inc.
(MMSI) delivered a total return of -3. 6%, compared to -93. 5% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: MMSI returned +214. 6% versus OMI's -86. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OMI or MMSI?
By beta (market sensitivity over 5 years), Merit Medical Systems, Inc.
(MMSI) is the lower-risk stock at 0. 71β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 103% more volatile than MMSI relative to the S&P 500.
05Which is growing faster — OMI or MMSI?
By revenue growth (latest reported year), Merit Medical Systems, Inc.
(MMSI) is pulling ahead at 11. 7% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Merit Medical Systems, Inc. grew EPS 4. 9% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, MMSI leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OMI or MMSI?
Merit Medical Systems, Inc.
(MMSI) is the more profitable company, earning 8. 5% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMSI leads at 12. 2% versus 1. 0% for OMI. At the gross margin level — before operating expenses — MMSI leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OMI or MMSI more undervalued right now?
On forward earnings alone, Owens & Minor, Inc.
(OMI) trades at 2. 3x forward P/E versus 15. 5x for Merit Medical Systems, Inc. — 13. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.
08Which pays a better dividend — OMI or MMSI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is OMI or MMSI better for a retirement portfolio?
For long-horizon retirement investors, Merit Medical Systems, Inc.
(MMSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), +214. 6% 10Y return). Both have compounded well over 10 years (MMSI: +214. 6%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OMI and MMSI?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.